These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 31138497)
21. [Mycobacterial lung disease in patients with cystic fibrosis--report of three cases]. Wyrostkiewicz D; Skorupa W; Jakubowska L; Zabost A; Kuś J Pneumonol Alergol Pol; 2014; 82(6):561-7. PubMed ID: 25339567 [TBL] [Abstract][Full Text] [Related]
22. Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus. Kirkwood ZI; Millar BC; Downey DG; Moore JE Int J Mycobacteriol; 2018; 7(4):358-360. PubMed ID: 30531035 [TBL] [Abstract][Full Text] [Related]
23. Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease. Olivier KN; Griffith DE; Eagle G; McGinnis JP; Micioni L; Liu K; Daley CL; Winthrop KL; Ruoss S; Addrizzo-Harris DJ; Flume PA; Dorgan D; Salathe M; Brown-Elliott BA; Gupta R; Wallace RJ Am J Respir Crit Care Med; 2017 Mar; 195(6):814-823. PubMed ID: 27748623 [TBL] [Abstract][Full Text] [Related]
24. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease. Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792 [TBL] [Abstract][Full Text] [Related]
25. Nontuberculous mycobacterial infections in cystic fibrosis. Martiniano SL; Nick JA Clin Chest Med; 2015 Mar; 36(1):101-15. PubMed ID: 25676523 [TBL] [Abstract][Full Text] [Related]
26. Microbiological profile, preclinical pharmacokinetics and efficacy of CRS0393, a novel antimycobacterial agent targeting MmpL3. Ochsner UA; De Groote MA; Jarvis TC; Liu H; Youmans T; Hoang T; Ribble W; Day J; Li W; Pearce C; Walz A; Panthi CM; Rimal B; Stevens CM; Zgurskaya HI; Jackson M; Ordway D; Gonzalez-Juarrero M; Sun X; Lamichhane G; Mason C Tuberculosis (Edinb); 2023 Jan; 138():102288. PubMed ID: 36470124 [TBL] [Abstract][Full Text] [Related]
37. In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex. Singh S; Bouzinbi N; Chaturvedi V; Godreuil S; Kremer L Clin Microbiol Infect; 2014 Dec; 20(12):O1124-7. PubMed ID: 25185732 [TBL] [Abstract][Full Text] [Related]
38. Nontuberculous mycobacteria in the setting of cystic fibrosis. Ebert DL; Olivier KN Clin Chest Med; 2002 Sep; 23(3):655-63. PubMed ID: 12371001 [TBL] [Abstract][Full Text] [Related]
39. In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease. Kim DH; Kim BG; Kim SY; Huh HJ; Lee NY; Koh WJ; Kim H; Kwon OJ; Jhun BW J Clin Med; 2021 Oct; 10(19):. PubMed ID: 34640599 [TBL] [Abstract][Full Text] [Related]